FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2120450971> ?p ?o ?g. }

• W2120450971 abstract "The objective of this study was to develop a process to maximize the safety and effectiveness of disclosing Positron Emission Tomography (PET) amyloid imaging results to cognitively normal older adults participating in Alzheimer's disease secondary prevention studies such as the Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Study.Using a modified Delphi Method to develop consensus on best practices, we gathered and analyzed data over three rounds from experts in two relevant fields: informed consent for genetic testing or human amyloid imaging.Experts reached consensus on (1) text for a brochure that describes amyloid imaging to a person who is considering whether to undergo such imaging in the context of a clinical trial, and (2) a process for amyloid PET result disclosure within such trials. Recommendations included: During consent, potential participants should complete an educational session, where they receive verbal and written information covering what is known and unknown about amyloid imaging, including possible results and their meaning, implications of results for risk of future cognitive decline, and information about Alzheimer's and risk factors. Participants should be screened for anxiety and depression to determine suitability to receive amyloid imaging information. The person conducting the sessions should check comprehension and be skilled in communication and recognizing distress. Imaging should occur on a separate day from consent, and disclosure on a separate day from imaging. Disclosure should occur in person, with time for questions. At disclosure, investigators should assess mood and willingness to receive results, and provide a written results report. Telephone follow-up within a few days should assess the impact of disclosure, and periodic scheduled assessments of depression and anxiety, with additional monitoring and follow-up for participants showing distress, should be performed.We developed a document for use with potential study participants to describe the process of amyloid imaging and the implications of amyloid imaging results; and a disclosure process with attention to ongoing monitoring of both mood and safety to receive this information. This document and process will be used in the A4 Study and can be adapted for other research settings." @default.
• W2120450971 created "2016-06-24" @default.
• W2120450971 creator A5001795846 @default.
• W2120450971 creator A5012342239 @default.
• W2120450971 creator A5033902830 @default.
• W2120450971 creator A5041531862 @default.
• W2120450971 creator A5050880670 @default.
• W2120450971 creator A5059549486 @default.
• W2120450971 creator A5087943563 @default.
• W2120450971 creator A5090842068 @default.
• W2120450971 date "2015-05-12" @default.
• W2120450971 modified "2023-10-18" @default.
• W2120450971 title "Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants" @default.
• W2120450971 cites W1963879048 @default.
• W2120450971 cites W1968359737 @default.
• W2120450971 cites W1982813521 @default.
• W2120450971 cites W1988404208 @default.
• W2120450971 cites W2013531430 @default.
• W2120450971 cites W2061522475 @default.
• W2120450971 cites W2066358461 @default.
• W2120450971 cites W2067728044 @default.
• W2120450971 cites W2080743918 @default.
• W2120450971 cites W2099180951 @default.
• W2120450971 cites W2099693452 @default.
• W2120450971 cites W2103346709 @default.
• W2120450971 cites W2110956006 @default.
• W2120450971 cites W2112579276 @default.
• W2120450971 cites W2114213877 @default.
• W2120450971 cites W2127176995 @default.
• W2120450971 cites W2129497119 @default.
• W2120450971 cites W2139204020 @default.
• W2120450971 cites W2153230739 @default.
• W2120450971 cites W2155783555 @default.
• W2120450971 cites W2156611511 @default.
• W2120450971 cites W2162667339 @default.
• W2120450971 cites W2167840686 @default.
• W2120450971 cites W2319797116 @default.
• W2120450971 doi "https://doi.org/10.1186/s13195-015-0112-7" @default.
• W2120450971 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4428104" @default.
• W2120450971 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25969699" @default.
• W2120450971 hasPublicationYear "2015" @default.
• W2120450971 type Work @default.
• W2120450971 sameAs 2120450971 @default.
• W2120450971 citedByCount "104" @default.
• W2120450971 countsByYear W21204509712015 @default.
• W2120450971 countsByYear W21204509712016 @default.
• W2120450971 countsByYear W21204509712017 @default.
• W2120450971 countsByYear W21204509712018 @default.
• W2120450971 countsByYear W21204509712019 @default.
• W2120450971 countsByYear W21204509712020 @default.
• W2120450971 countsByYear W21204509712021 @default.
• W2120450971 countsByYear W21204509712022 @default.
• W2120450971 countsByYear W21204509712023 @default.
• W2120450971 crossrefType "journal-article" @default.
• W2120450971 hasAuthorship W2120450971A5001795846 @default.
• W2120450971 hasAuthorship W2120450971A5012342239 @default.
• W2120450971 hasAuthorship W2120450971A5033902830 @default.
• W2120450971 hasAuthorship W2120450971A5041531862 @default.
• W2120450971 hasAuthorship W2120450971A5050880670 @default.
• W2120450971 hasAuthorship W2120450971A5059549486 @default.
• W2120450971 hasAuthorship W2120450971A5087943563 @default.
• W2120450971 hasAuthorship W2120450971A5090842068 @default.
• W2120450971 hasBestOaLocation W21204509711 @default.
• W2120450971 hasConcept C118552586 @default.
• W2120450971 hasConcept C139265228 @default.
• W2120450971 hasConcept C142724271 @default.
• W2120450971 hasConcept C151730666 @default.
• W2120450971 hasConcept C15744967 @default.
• W2120450971 hasConcept C169900460 @default.
• W2120450971 hasConcept C204787440 @default.
• W2120450971 hasConcept C2779134260 @default.
• W2120450971 hasConcept C2779343474 @default.
• W2120450971 hasConcept C2779483572 @default.
• W2120450971 hasConcept C558461103 @default.
• W2120450971 hasConcept C68122502 @default.
• W2120450971 hasConcept C70410870 @default.
• W2120450971 hasConcept C71924100 @default.
• W2120450971 hasConcept C86803240 @default.
• W2120450971 hasConceptScore W2120450971C118552586 @default.
• W2120450971 hasConceptScore W2120450971C139265228 @default.
• W2120450971 hasConceptScore W2120450971C142724271 @default.
• W2120450971 hasConceptScore W2120450971C151730666 @default.
• W2120450971 hasConceptScore W2120450971C15744967 @default.
• W2120450971 hasConceptScore W2120450971C169900460 @default.
• W2120450971 hasConceptScore W2120450971C204787440 @default.
• W2120450971 hasConceptScore W2120450971C2779134260 @default.
• W2120450971 hasConceptScore W2120450971C2779343474 @default.
• W2120450971 hasConceptScore W2120450971C2779483572 @default.
• W2120450971 hasConceptScore W2120450971C558461103 @default.
• W2120450971 hasConceptScore W2120450971C68122502 @default.
• W2120450971 hasConceptScore W2120450971C70410870 @default.
• W2120450971 hasConceptScore W2120450971C71924100 @default.
• W2120450971 hasConceptScore W2120450971C86803240 @default.
• W2120450971 hasIssue "1" @default.
• W2120450971 hasLocation W21204509711 @default.
• W2120450971 hasLocation W21204509712 @default.
• W2120450971 hasLocation W21204509713 @default.
• W2120450971 hasLocation W21204509714 @default.
• W2120450971 hasLocation W21204509715 @default.
• W2120450971 hasLocation W21204509716 @default.

• next